title: Long-term effects of insulin glargine on the risk of breast cancer.
abstract: OBJECTIVE
  There have been growing concerns regarding the long-term effects of insulin glargine (A21Gly,B31Arg,B32Arg human insulin) on the risk of breast cancer.
  
  
  METHODS
  We used the UK's General Practice Research Database (GPRD) to identify a cohort of women aged 40 years or over with type 2 diabetes, treated with insulin during 2002-2006 and followed until the first breast cancer diagnosis or 31 December 2009. After the users of insulin glargine had been matched with users of other insulins on age, calendar time and duration of prior insulin use, the HR of breast cancer associated with insulin glargine use was estimated using a Cox proportional hazards model, adjusted for known risk factors for breast cancer.
  
  
  RESULTS
  The cohort comprised 15,227 women, including 4,579 glargine users and 10,648 users of other insulins, of which 246 developed breast cancer during up to 8 years follow-up (incidence rate 4.1 per 1,000 per year). Insulin glargine use was not associated with an increased risk of breast cancer during the first 5 years of use (HR 0.9; 95% CI 0.7-1.3). The risk tended to increase after 5 years (HR 1.8; 95% CI 0.8-4.0), and significantly so for the women who had been on insulin before starting glargine (HR 2.7; 95% CI 1.1-6.5).
  
  
  CONCLUSIONS
  The risk of breast cancer in women with type 2 diabetes is not increased during the first 5 years of insulin glargine use. However, longer-term use may increase this risk, particularly in women with longstanding use of insulin before starting insulin glargine.
authors: Center for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, Canada H3T 1E2. samy.suissa@mcgill.ca
authors: S
authors: S
authors: Suissa
authors: L
authors: L
authors: Azoulay
authors: S
authors: S
authors: Dell'Aniello
authors: M
authors: M
authors: Evans
authors: J
authors: J
authors: Vora
authors: M
authors: M
authors: Pollak
references: Diabetologia. 2010 Apr;53(4):790-2; author reply 793-4
references: 20099058
references: Diabetologia. 2009 Sep;52(9):1755-65
references: 19603149
references: Arch Physiol Biochem. 2008 Feb;114(1):17-22
references: 18465355
references: Diabetologia. 2009 Dec;52(12):2507-12
references: 19838665
references: Lancet. 1997 Oct 11;350(9084):1097-9
references: 10213569
references: BJOG. 2008 Jan;115(2):169-75; discussion 175
references: 18081598
references: Diabetes Care. 2010 Jun;33(6):1304-8
references: 20299480
references: Stat Med. 1996 Dec 15;15(23):2589-601
references: 8961465
references: Nature. 1988 Jun 16;333(6174):679-82
references: 3287182
references: Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005613
references: 17443605
references: Diabetologia. 2009 Dec;52(12):2499-506
references: 19756478
references: Ann Intern Med. 1997 Dec 1;127(11):1023-8
references: 9412284
references: Diabetologia. 2009 Sep;52(9):1732-44
references: 19565214
references: PLoS One. 2010 Mar 04;5(3):e9540
references: 20209060
references: Diabetologia. 2009 Sep;52(9):1766-77
references: 19572116
references: Prostate. 2009 Jan 1;69(1):33-40
references: 18785179
references: Exp Cell Res. 1999 Nov 25;253(1):1-6
references: 10579905
references: Diabetologia. 2010 Dec;53(12):2667-75
references: 20835859
references: N Engl J Med. 1994 Jul 7;331(1):5-9
references: 8202106
references: Diabetologia. 2009 Sep;52(9):1745-54
references: 19588120
references: Diabetes Care. 2003 Jun;26(6):1752-8
references: 12766105
references: Nat Rev Cancer. 2008 Dec;8(12):915-28
references: 19029956
references: Endocr Relat Cancer. 2009 Jun;16(2):429-41
references: 19153208
references: Arch Physiol Biochem. 2010 May;116(2):73-8
references: 20199195
references: Diabetologia. 2010 May;53(5):802-8
references: 20177658
references: CMAJ. 2009 Feb 17;180(4):385-97
references: 19221352
references: Cancer Res. 2008 Dec 15;68(24):10238-46
references: 19074892
references: Diabetes. 2000 Jun;49(6):999-1005
references: 10866053
references: Biochem J. 1996 Apr 1;315 ( Pt 1):271-9
references: 8670118
references: Lancet. 2009 Aug 15;374(9689):511-3
references: 19616841
references: Diabetes Care. 2010 Sep;33(9):1997-2003
references: 20551014